Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15910530 | 1.00 | PTGS1 (0.41) | PTGS1SLC7A11KDM4EMAPTTHRB | |
| SCHEMBL5972752 | 0.72 | — | — | |
| Cysteine SCHEMBL8003519 | 0.71 | PTGS1 (0.70) | PTGS1SLC7A11KDM4EMAPTTHRB | |
| Cysteine SCHEMBL8003521 | 0.71 | PTGS1 (0.70) | PTGS1SLC7A11KDM4EMAPTTHRB | |
| SCHEMBL8714505 | 0.69 | KDM4E (0.32) | PTGS1KDM4ENFKB1 | |
| SCHEMBL388604 | 0.68 | PTGS1 (0.46) | PTGS1SLC7A11KDM4EMAPTTHRB | |
| SCHEMBL388605 | 0.68 | PTGS1 (0.46) | PTGS1SLC7A11KDM4EMAPTTHRB | |
| SCHEMBL12852246 | 0.68 | — | — | |
| SCHEMBL5943374 | 0.68 | — | — | |
| SCHEMBL6866882 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6777535-B1 | USEFUL FOR TREATING CONDITIONS WHICH ARISE OR ARE EXACERBATED BY ANGIOGENESIS | ABBOTT LABORATORIES | 2004-08-17 | — | — | US | claimed |
| EP-1242455-A1 | N-ALKYLATED PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY | Abbott Laboratories (US) | 2002-09-25 | — | — | EP | claimed |
| WO-2001038397-A1 | N-ALKYLATED PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY | ABBOTT LABORATORIES (US) | 2001-05-31 | — | — | WO | claimed |
| US-20140350218-A1 | ALPHA-CONOTOXIN PEPTIDES | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2014-11-27 | — | — | US | disclosed |
| US-8735541-B2 | α-Conotoxin peptides | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2014-05-27 | — | — | US | disclosed |
| US-20130338338-A1 | ALPHA-CONOTOXIN PEPTIDES | COGNETIX, INC. (US) | 2013-12-19 | — | — | US | disclosed |
| US-8487075-B2 | Alpha-conotoxin peptides | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2013-07-16 | — | — | US | disclosed |
| US-20120149869-A1 | ALPHA-CONOTOXIN PEPTIDES | COGNETIX, INC. (US) | 2012-06-14 | — | — | US | disclosed |
| US-8110549-B2 | Alpha-conotoxin peptides | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2012-02-07 | — | — | US | disclosed |
| US-20110166322-A1 | ALPHA-CONOTOXIN PEPTIDES | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2011-07-07 | — | — | US | disclosed |
| US-7902153-B2 | Alpha-conotoxin peptides | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2011-03-08 | — | — | US | disclosed |
| EP-1151100-A1 | TAU-CONOTOXIN PEPTIDES | University of Utah Research Foundation (US) | 2001-11-07 | — | — | EP | disclosed |
| US-6265541-B1 | FOR TREATING DISORDERS REGULATED AT NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS, INCLUDING CARDIOVASCULAR DISORDERS, GASTRIC MOTILITY DISORDERS, URINARY INCONTINENCE, NICOTINE ADDICTION, MOOD DISORDERS | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2001-07-24 | — | — | US | disclosed |
| WO-2001049312-A2 | O-SUPERFAMILY CONOTOXIN PEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2001-07-12 | — | — | WO | disclosed |
| WO-2001038397-A1 | N-ALKYLATED PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY | ABBOTT LABORATORIES (US) | 2001-05-31 | — | — | WO | disclosed |
| WO-2000046371-A1 | TAU-CONOTOXIN PEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2000-08-10 | — | — | WO | disclosed |
| WO-2000044769-A1 | CONOTOXIN PEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2000-08-03 | — | — | WO | disclosed |
| WO-1999033482-A1 | USES OF ALPHA-CONOTOXIN PEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1999-07-08 | — | — | WO | disclosed |
| US-5866682-A | SHORT PEPTIDES ABOUT 14-17 RESIDUES IN LENGTH, WHICH ARE NATURALLY AVAILABLE IN MINUTE AMOUNTS IN THE VENOM OF THE CONE SNAILS. | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1999-02-02 | — | — | US | disclosed |
| WO-1998051322-A1 | CONOPEPTIDES AuIA, AuIB AND AuIC | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1998-11-19 | — | — | WO | disclosed |